CKI HOLDINGS
01038
BJ ENT WATER
00371
CEB BANK
06818
CHINA UNICOM
00762
BANKCOMM
03328
HK Stock MarketDetailed Quotes
06160 BEIGENE
- 105.400
- +0.700+0.67%
Noon Break Dec 23 11:59 CST
145.88BMarket Cap-21.82P/E (TTM)
106.300High104.300Low478.20KVolume106.000Open104.700Pre Close50.25MTurnover0.04%Turnover RatioLossP/E (Static)1.38BShares153.00052wk High5.55P/B133.76BFloat Cap75.45052wk Low--Dividend TTM1.27BShs Float278.600Historical High--Dividend LFY1.91%Amplitude61.050Historical Low105.071Avg Price100Lot Size--Div YieldTTM--Div Yield LFY
About BEIGENE Company
The company's mission is to become a global leader in the discovery, development and commercialization of innovative molecular-targeted immuno-oncology drugs to treat cancer. The company focuses on R&D, production and commercialization of innovative drugs. The main products are anti-tumor drugs, etc.
Company Profile
Symbol06160
Company NameBEIGENE
ISINKYG1146Y1017
Listing DateAug 8, 2018
Issue Price108.00
Shares Offered65.60M share(s)
FoundedJun 28, 2018
Registered AddressCayman Islands
Chairmanleiqiang ou
Secretaryqingling zhou
Audit InstitutionErnst & Young, Ernst & Young LLP, Ernst & Young AG, Ernst & Young AG
Company CategoryOverseas registration of Mainland Individuals control
Registered OfficeMourant Governance Services (Cayman) Limited 94 Solaris Avenue Camana Bay Grand Cayman KY1-1108, Cayman Islands
Head Office and Principal Place of BusinessRoom 1901, 19th floor, Lee Garden Phase 1, 33 Hysan Avenue, Causeway Bay, Hong Kong
Fiscal Year Ends12-31
Employees10000
MarketHong Kong motherboard
Phone010-58958058
Fax010-85148699
Emailir@beigene.com
Websitehttp://www.beigene.com
BusinessBeiGene is a global, commercial-stage biotechnology company focused on the research, development, production and commercialization of innovative medicines.
Company Executives
- Name
- Position
- Salary
- leiqiang ou
- Presidencies, CEOs, Executive Director, Authorized Representative
- 16.74M
- xiaodong wang
- Non-executive Directors
- 4.27M
- Olivier Brandicourt
- Independent Non-Executive Director, Audit Committee Members
- --
- Margaret Han Dugan
- Independent Non-Executive Director, Remuneration Committee Chairman, Member of the Advisory Committee on Commercial and Medical Affairs
- 516.00K
- Michael Goller
- Independent Non-Executive Director, Nomination and Corporate Governance Committee Members
- 487.00K
- Anthony C. Hooper
- Independent Non-Executive Director, Chairman of the Audit Committee, Nomination Committee Members
- 518.00K
- Ranjeev Krishana
- Independent Non-Executive Director, Remuneration Committee Members
- 492.00K
- Shalini Sharp
- Independent Non-Executive Director, Audit Committee Members
- --
- Alessandro Riva
- Independent Non-Executive Director, Nomination Committee Members
- 497.00K
- Corazon (Corsee) D. Sanders
- Independent Non-Executive Director, Audit Committee Members
- 507.00K
- qingqing yi
- Independent Non-Executive Director, Remuneration Committee Members
- 492.00K
- xiaobin wu
- President, General Manager, Chief Operating Officer
- --
- Aaron Rosenberg
- Chief Financial Officer
- --
- lai wang
- Global Head of R&D
- --
- Chan Lee
- Senior Vice President, General Counsel
- --
- qingling zhou
- Authorized Representative, Company Secretary
- --
Trending HK Stocks
HK Dividend Stocks HK Dividend Stocks
Dividend stocks are stocks of companies in the HK stock market that regularly distribute dividends to shareholders, generally representing stable businesses. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in HK dividend stocks, ranked from highest to lowest based on real-time market data. Dividend stocks are stocks of companies in the HK stock market that regularly distribute dividends to shareholders, generally representing stable businesses. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in HK dividend stocks, ranked from highest to lowest based on real-time market data.
